Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 36 | 2026 | 525 | 10.060 |
Why?
|
| Autism Spectrum Disorder | 8 | 2025 | 420 | 3.360 |
Why?
|
| Intellectual Disability | 5 | 2024 | 178 | 2.070 |
Why?
|
| Child Development | 4 | 2026 | 484 | 1.420 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2023 | 427 | 1.070 |
Why?
|
| Language Development Disorders | 2 | 2025 | 41 | 1.010 |
Why?
|
| Gestures | 1 | 2025 | 7 | 0.880 |
Why?
|
| Psychotropic Drugs | 2 | 2024 | 78 | 0.840 |
Why?
|
| Autistic Disorder | 2 | 2024 | 217 | 0.790 |
Why?
|
| Catatonia | 1 | 2022 | 13 | 0.730 |
Why?
|
| Child, Preschool | 18 | 2025 | 11837 | 0.640 |
Why?
|
| Motor Skills | 3 | 2026 | 104 | 0.630 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2023 | 226 | 0.620 |
Why?
|
| Child | 16 | 2025 | 22680 | 0.460 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2024 | 1369 | 0.440 |
Why?
|
| Humans | 39 | 2026 | 145491 | 0.430 |
Why?
|
| Language Development | 2 | 2025 | 59 | 0.420 |
Why?
|
| Social Skills | 1 | 2014 | 32 | 0.410 |
Why?
|
| Adolescent | 15 | 2025 | 22485 | 0.390 |
Why?
|
| Mental Disorders | 1 | 2022 | 1157 | 0.380 |
Why?
|
| Infant | 12 | 2026 | 10064 | 0.370 |
Why?
|
| Male | 22 | 2026 | 72817 | 0.350 |
Why?
|
| Overweight | 2 | 2022 | 607 | 0.330 |
Why?
|
| Female | 20 | 2026 | 78763 | 0.310 |
Why?
|
| Adolescent Behavior | 1 | 2014 | 497 | 0.290 |
Why?
|
| Prospective Studies | 5 | 2024 | 8039 | 0.280 |
Why?
|
| Young Adult | 10 | 2025 | 14192 | 0.280 |
Why?
|
| Cyclin A | 1 | 2007 | 17 | 0.270 |
Why?
|
| Spermatogenesis | 1 | 2007 | 91 | 0.260 |
Why?
|
| Locomotion | 1 | 2026 | 102 | 0.230 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 320 | 0.220 |
Why?
|
| Caregivers | 2 | 2024 | 1070 | 0.220 |
Why?
|
| Child Language | 1 | 2025 | 21 | 0.220 |
Why?
|
| Arthritis | 1 | 2025 | 96 | 0.220 |
Why?
|
| Socialization | 1 | 2024 | 24 | 0.210 |
Why?
|
| Feasibility Studies | 3 | 2025 | 1119 | 0.210 |
Why?
|
| Play and Playthings | 1 | 2024 | 35 | 0.210 |
Why?
|
| Pilot Projects | 3 | 2025 | 1896 | 0.210 |
Why?
|
| Employment, Supported | 1 | 2024 | 3 | 0.210 |
Why?
|
| New England | 1 | 2024 | 37 | 0.200 |
Why?
|
| Emotions | 2 | 2023 | 579 | 0.200 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2007 | 536 | 0.200 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 631 | 0.200 |
Why?
|
| Electroconvulsive Therapy | 1 | 2022 | 15 | 0.190 |
Why?
|
| Comorbidity | 2 | 2025 | 1659 | 0.180 |
Why?
|
| Employment | 1 | 2024 | 187 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2024 | 3897 | 0.170 |
Why?
|
| Metabolic Diseases | 1 | 2022 | 114 | 0.170 |
Why?
|
| Developmental Disabilities | 1 | 2024 | 281 | 0.170 |
Why?
|
| Behavior Therapy | 1 | 2024 | 301 | 0.170 |
Why?
|
| Electroencephalography | 1 | 2024 | 563 | 0.160 |
Why?
|
| Cognition | 2 | 2021 | 1268 | 0.160 |
Why?
|
| Quality of Life | 2 | 2023 | 3195 | 0.160 |
Why?
|
| Attention | 1 | 2024 | 463 | 0.160 |
Why?
|
| Language | 1 | 2023 | 323 | 0.160 |
Why?
|
| Longitudinal Studies | 2 | 2026 | 2950 | 0.160 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 1487 | 0.160 |
Why?
|
| Attitude | 1 | 2021 | 260 | 0.150 |
Why?
|
| Brain Stem | 1 | 2019 | 98 | 0.140 |
Why?
|
| Gray Matter | 1 | 2019 | 92 | 0.140 |
Why?
|
| Brain | 5 | 2024 | 2944 | 0.140 |
Why?
|
| Cross-Sectional Studies | 3 | 2025 | 5891 | 0.130 |
Why?
|
| Adult | 9 | 2025 | 40707 | 0.130 |
Why?
|
| Age Factors | 1 | 2024 | 3340 | 0.120 |
Why?
|
| Thyroid Diseases | 1 | 2017 | 44 | 0.120 |
Why?
|
| Spasms, Infantile | 1 | 2019 | 138 | 0.120 |
Why?
|
| Hypothyroidism | 1 | 2017 | 67 | 0.120 |
Why?
|
| Communication | 1 | 2023 | 975 | 0.120 |
Why?
|
| Parents | 2 | 2025 | 1404 | 0.120 |
Why?
|
| Cohort Studies | 3 | 2022 | 5992 | 0.120 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1058 | 0.120 |
Why?
|
| Genetic Counseling | 1 | 2016 | 81 | 0.120 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 471 | 0.110 |
Why?
|
| Retrospective Studies | 6 | 2024 | 17269 | 0.110 |
Why?
|
| Sexuality | 1 | 2014 | 32 | 0.100 |
Why?
|
| Multicenter Studies as Topic | 1 | 2015 | 411 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 2022 | 1153 | 0.100 |
Why?
|
| Puberty | 1 | 2014 | 135 | 0.100 |
Why?
|
| Celiac Disease | 1 | 2016 | 310 | 0.100 |
Why?
|
| Transition to Adult Care | 1 | 2014 | 101 | 0.090 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 279 | 0.090 |
Why?
|
| Cognitive Dysfunction | 1 | 2017 | 470 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 2185 | 0.080 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2014 | 302 | 0.080 |
Why?
|
| Registries | 2 | 2017 | 2410 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2015 | 1500 | 0.070 |
Why?
|
| Gift Giving | 1 | 2008 | 9 | 0.070 |
Why?
|
| Cyclin B2 | 1 | 2007 | 1 | 0.070 |
Why?
|
| Cyclin A1 | 1 | 2007 | 5 | 0.070 |
Why?
|
| Cyclin B | 1 | 2007 | 15 | 0.070 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2007 | 68 | 0.070 |
Why?
|
| Testis | 1 | 2007 | 162 | 0.060 |
Why?
|
| Infant, Newborn | 4 | 2021 | 6437 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 1585 | 0.060 |
Why?
|
| Interprofessional Relations | 1 | 2008 | 275 | 0.060 |
Why?
|
| DNA Repair | 1 | 2007 | 256 | 0.060 |
Why?
|
| Cell Cycle | 1 | 2007 | 595 | 0.050 |
Why?
|
| Theta Rhythm | 1 | 2024 | 18 | 0.050 |
Why?
|
| Depression | 1 | 2014 | 1573 | 0.050 |
Why?
|
| Brain Waves | 1 | 2024 | 45 | 0.050 |
Why?
|
| Students, Medical | 1 | 2008 | 375 | 0.050 |
Why?
|
| Physician-Patient Relations | 1 | 2008 | 590 | 0.050 |
Why?
|
| Hyperphagia | 1 | 2023 | 38 | 0.050 |
Why?
|
| Developed Countries | 1 | 2022 | 38 | 0.050 |
Why?
|
| India | 1 | 2022 | 220 | 0.040 |
Why?
|
| Biomarkers | 2 | 2024 | 4283 | 0.040 |
Why?
|
| Entorhinal Cortex | 1 | 2021 | 15 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2022 | 133 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2022 | 168 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2024 | 293 | 0.040 |
Why?
|
| Income | 1 | 2022 | 201 | 0.040 |
Why?
|
| DNA | 1 | 2007 | 1451 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 422 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2007 | 3125 | 0.040 |
Why?
|
| Weight Gain | 1 | 2023 | 557 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2024 | 667 | 0.040 |
Why?
|
| Boston | 1 | 2019 | 93 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 2594 | 0.030 |
Why?
|
| Lipids | 1 | 2022 | 709 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2022 | 476 | 0.030 |
Why?
|
| Thyroid Function Tests | 1 | 2017 | 19 | 0.030 |
Why?
|
| Thyroxine | 1 | 2017 | 65 | 0.030 |
Why?
|
| Mass Screening | 1 | 2025 | 1358 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2025 | 3424 | 0.030 |
Why?
|
| Thyrotropin | 1 | 2017 | 119 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2017 | 89 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2019 | 246 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2024 | 3619 | 0.030 |
Why?
|
| Mice | 2 | 2017 | 18338 | 0.030 |
Why?
|
| Middle Aged | 3 | 2025 | 36176 | 0.030 |
Why?
|
| Interdisciplinary Studies | 1 | 2015 | 30 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 287 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2022 | 2425 | 0.030 |
Why?
|
| Biopsy | 1 | 2016 | 1081 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 464 | 0.020 |
Why?
|
| Animals | 2 | 2017 | 38141 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2019 | 1187 | 0.020 |
Why?
|
| Exercise | 1 | 2022 | 2192 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5426 | 0.020 |
Why?
|
| Obesity | 1 | 2022 | 3076 | 0.020 |
Why?
|
| Persuasive Communication | 1 | 2008 | 14 | 0.020 |
Why?
|
| Risk Factors | 1 | 2022 | 10874 | 0.020 |
Why?
|
| Problem Solving | 1 | 2008 | 158 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2022 | 11831 | 0.020 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2008 | 207 | 0.010 |
Why?
|
| Decision Making | 1 | 2008 | 979 | 0.010 |
Why?
|
| United States | 1 | 2015 | 16115 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 26125 | 0.010 |
Why?
|